200,000+ products from a single source!
sales@angenechem.com
Home > Imidazoles > 1130067-18-3
1130067-18-3 | N-(2-{4-[2-oxo-2,3-dihydro-1H-benzo(d)iMidazol-1-yl]piperidin-1-yl}ethyl)-2-naphthaMide
CAS No: 1130067-18-3 Catalog No: AG008YXS MDL No:
Product Description
Catalog Number:
AG008YXS
Chemical Name:
N-(2-{4-[2-oxo-2,3-dihydro-1H-benzo(d)iMidazol-1-yl]piperidin-1-yl}ethyl)-2-naphthaMide
CAS Number:
1130067-18-3
IUPAC Name:
N-[2-[4-(2-oxo-3H-benzimidazol-1-yl)piperidin-1-yl]ethyl]naphthalene-2-carboxamide
InChI:
InChI=1S/C25H26N4O2/c30-24(20-10-9-18-5-1-2-6-19(18)17-20)26-13-16-28-14-11-21(12-15-28)29-23-8-4-3-7-22(23)27-25(29)31/h1-10,17,21H,11-16H2,(H,26,30)(H,27,31)
InChI Key:
IXLLRNNFUYEADZ-UHFFFAOYSA-N
Properties
Complexity:
647
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
414.206g/mol
Formal Charge:
0
Heavy Atom Count:
31
Hydrogen Bond Acceptor Count:
3
Hydrogen Bond Donor Count:
2
Isotope Atom Count:
0
Molecular Weight:
414.509g/mol
Monoisotopic Mass:
414.206g/mol
Rotatable Bond Count:
5
Topological Polar Surface Area:
64.7A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
4.2
Literature
| Title | Journal |
|---|---|
| Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part II. Identification of the 1,3,8-triazaspiro[4,5]decan-4-one privileged structure that engenders PLD2 selectivity. | Bioorganic & medicinal chemistry letters 20090415 |
| Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part I: Impact of alternative halogenated privileged structures for PLD1 specificity. | Bioorganic & medicinal chemistry letters 20090401 |
| Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness. | Nature chemical biology 20090201 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.